Last10K.com

Jmu Ltd (MFH) SEC Filing 6-K Foreign Issuer report for the period ending Monday, March 2, 2020

Athenex, Inc.

HISTORY TOOLS
CIK: 1527762 Ticker: ATNX

View differences made from one to another to evaluate Athenex, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Athenex, Inc..

Continue

Assess how Athenex, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Athenex, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Athenex, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: ATNX
CIK: 1300699
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001104659-20-027856
Submitted to the SEC: Mon Mar 02 2020 4:01:35 PM EST
Accepted by the SEC: Mon Mar 02 2020
Period: Monday, March 2, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/atnx/0001104659-20-027856.htm